A recent study in mice demonstrated that mildly increasing PPARα expression in the progressive phase of heart failure, when FAO is decreased, maintains myocardial function and energetics, suggesting that modulating substrate utilization may be a promising therapeutic strategy for heart failure (175). Here, PPARA is linked to heart failure.